Ursodeoxycholic acid in complex treatment of patients with a metabolic syndrome
Abstract
Patients with metabolic syndrome who got ursodeoxycholic acid in complex treatment were examined. The indices of immunoreactive insulin, leptin were studied in dynamics with the use of immunoenzymatic method, the values of lipid spectrum, the data of ultrasound investigation of liver were determined.
It was revealed that inclusion of ursodeoxycholic acid into the complex treatment of patients with metabolic syndrome lead to the decrease of indices of immunoreactive insulin, leptin, atherogenic fractions of lipids playing a leading role in the development and progressing of metabolic syndrome.
About the Authors
O. A. Tanchenko
Amur State Medical Academy
Russian Federation
Russian Federation
Blagoveshchensk
S. V. Naryshkina
Amur State Medical Academy
Russian Federation
Russian Federation
Blagoveshchensk
References
1. Ginsburg M.M. Obesity. Influence on the development of metabolic syndrome. Prophylaxis and treatment/ M.M. Ginsburg. - M.: Medicalpractice, 2008. - 128 p.
2. Dedov I.I., Melnichenko G.A. Obesity/ I.I. Dedov., G.A. Melnichenko /M.: Med. inform. agency, 2008. - 456 p.
3. Mamedov M.N. Are diagnostics and treatment of metabolic syndrome possible in real practice? / M.N. Mamedov // Doctor in charge.- 2006.- № 6.- Р. 34-39.
4. Mendez-Sanchez N., Arrese M. Current concept in pathogenesis of fatty liver disease/ N. Mendez-Sanchez, M. Arrese-Liver. 2007. - Vol. 27, № 33. - P. 423-425.
Review
For citations:
Tanchenko O.A., Naryshkina S.V. Ursodeoxycholic acid in complex treatment of patients with a metabolic syndrome. Yakut Medical Journal. 2010;(4):38-40.
Views:
19
Email this article 